NCT00132925View on ClinicalTrials.gov

An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

February 28, 2006

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

Triamcinolone

Trial Locations (1)

08807

Sanofi-Aventis, Inc., Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY